{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:57:59Z","timestamp":1772521079264,"version":"3.50.1"},"reference-count":13,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v106.adv-2025-0090","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:14:18Z","timestamp":1772518458000},"source":"Crossref","is-referenced-by-count":0,"title":["Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights"],"prefix":"10.2340","volume":"106","author":[{"given":"Xun","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"143207","doi-asserted-by":"crossref","unstructured":"Ba\u011fc\u0131 IS, Horv\u00e1th ON, Ruzicka T, S\u00e1rdy M. Bullous pemphigoid. Autoimmun Rev 2017; 16: 445\u2013455","DOI":"10.1016\/j.autrev.2017.03.010"},{"key":"143208","doi-asserted-by":"crossref","unstructured":"Verheyden M, Murrell D, Bilgic A. 12871 A systematic review of drug-induced pemphigoid. J Am Acad Dermatol 2020; 83: AB113","DOI":"10.1016\/j.jaad.2020.06.539"},{"key":"143209","doi-asserted-by":"crossref","unstructured":"Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013; 369: 699\u2013710","DOI":"10.1056\/NEJMoa1215734"},{"key":"143210","doi-asserted-by":"crossref","unstructured":"Magdaleno-Tapial J, Ferrer-Guill\u00e9n B, Valenzuela-O\u00f1ate C, Esteve-Mart\u00ednez A. Acneiform eruption induced by vedolizumab. Dermatol Online J 2018; 24: 13030\/qt0vg996xr.","DOI":"10.5070\/D32410041733"},{"key":"143211","doi-asserted-by":"crossref","unstructured":"Sody E, K\u00f6rber A. Psoriasis Induced by Vedolizumab. Inflamm Bowel Dis 2017; 23: E9\u2013E11","DOI":"10.1097\/MIB.0000000000001011"},{"key":"143212","doi-asserted-by":"crossref","unstructured":"Odom MB, Chen JN, Echavarria JF, Gilson RT. A case of bullous pemphigoid in an ulcerative colitis patient treated with vedolizumab. JAAD Case Rep 2025; 66: 176\u2013179","DOI":"10.1016\/j.jdcr.2025.09.033"},{"key":"143213","doi-asserted-by":"crossref","unstructured":"Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol 1978; 62: 162\u2013166","DOI":"10.1016\/0091-6749(78)90101-X"},{"key":"143214","doi-asserted-by":"crossref","unstructured":"Gorfu G, Rivera-Nieves J, Ley K. Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 2009; 9: 836\u2013850","DOI":"10.2174\/156652409789105525"},{"key":"143215","doi-asserted-by":"crossref","unstructured":"Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339: 269\u2013280","DOI":"10.1007\/s00441-009-0834-6"},{"key":"143216","doi-asserted-by":"crossref","unstructured":"Aho S, Uitto J. Direct interaction between the intracellular domains of bullous pemphigoid antigen 2 (BP180) and beta 4 integrin, hemidesmosomal components of basal keratinocytes. Biochem Biophys Res Commun 1998; 243: 694\u2013699.","DOI":"10.1006\/bbrc.1998.8162"},{"key":"143217","doi-asserted-by":"crossref","unstructured":"Sedano R, Dhaliwal I, Ramsewak D, Jairath V. Drug-induced lupus associated with vedolizumab in a patient with Crohn\u2019s disease. Inflamm Bowel Dis 2021; 27: e47\u2013e48","DOI":"10.1093\/ibd\/izaa331"},{"key":"143218","doi-asserted-by":"crossref","unstructured":"Licata G, Gambardella A, De Rosa A, Calabrese G, Alfano R, Argenziano G. Hidradenitis suppurativa caused by vedolizumab. Dermatitis 2021; 32: e23\u2013e24","DOI":"10.1097\/DER.0000000000000610"},{"key":"143219","doi-asserted-by":"crossref","unstructured":"Choe SI, Bourgeois J, Nidamanuri S, Rubenzik R. Pyoderma gangrenosum in an ulcerative colitis patient on vedolizumab. Cureus 2024; 16: e69219","DOI":"10.7759\/cureus.69219"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45637\/53040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45637\/53041","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45637\/53042","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45637\/53040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:14:38Z","timestamp":1772518478000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/45637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":13,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0090","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}